Uniform sarcolemmal dystrophin expression is required to prevent extracellular microRNA release and improve dystrophic pathology-Reference-Cited by-同舟云学术

Uniform sarcolemmal dystrophin expression is required to prevent extracellular microRNA release and improve dystrophic pathology

Published:2020-04 Issue:2 Volume:11 Page:578-593
ISSN:2190-5991
Container-title:Journal of Cachexia, Sarcopenia and Muscle
language:en
Short-container-title:Journal of Cachexia, Sarcopenia and Muscle

Author:

Westering Tirsa L.E.¹,Lomonosova Yulia¹²,Coenen‐Stass Anna M.L.¹,Betts Corinne A.¹²,Bhomra Amarjit¹²,Hulsker Margriet³,Clark Lucy E.²,McClorey Graham¹²,Aartsma‐Rus Annemieke³,Putten Maaike³,Wood Matthew J.A.¹²,Roberts Thomas C.¹²⁴^ORCID

Affiliation:

1. Department of Physiology, Anatomy and GeneticsUniversity of Oxford South Parks Road Oxford UK

2. Department of PaediatricsUniversity of Oxford South Parks Road Oxford UK

3. Department of Human GeneticsLeiden University Medical Center Leiden the Netherlands

4. Sanford Burnham Prebys Medical Discovery Institute, Development, Aging and Regeneration Program La Jolla CA USA

Funder

Muscular Dystrophy UK

Medical Research Council

Publisher

Wiley

Subject

Physiology (medical),Orthopedics and Sports Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcsm.12506

Reference69 articles.

1. Membrane organization of the dystrophin-glycoprotein complex

2. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin

3. Dystrophin protects the sarcolemma from stresses developed during muscle contraction.

4. Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: Evidence for failure of dystrophin production in dystrophin-competent myonuclei

5. Heterozygotic gene expression in endomyocardial biopsies a new diagnostic tool confirms the Duchenne carrier status

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiR-21 regulates skeletal muscle atrophy and fibrosis by targeting TGF-beta/SMAD7-SMAD2/3 signaling pathway;Heliyon;2024-06

2. Therapeutic approaches for Duchenne muscular dystrophy;Nature Reviews Drug Discovery;2023-08-31

3. Enhancing the Effectiveness of Oligonucleotide Therapeutics Using Cell-Penetrating Peptide Conjugation, Chemical Modification, and Carrier-Based Delivery Strategies;Pharmaceutics;2023-04-03

4. Dystrophin myonuclear domain restoration governs treatment efficacy in dystrophic muscle;Proceedings of the National Academy of Sciences;2023-01-03

5. Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD;Molecular Therapy - Nucleic Acids;2022-12